XML 43 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets and Liabilities

Deferred tax assets and liabilities

Net deferred tax assets are comprised of the following as of December 31, 2022 and 2021 (in thousands):

 

 

 

December 31,

 

 

 

2022

 

 

2021

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

69,044

 

 

$

59,453

 

Capitalized research expenses

 

 

22,123

 

 

 

3,598

 

R&D and other tax credits

 

 

22,210

 

 

 

12,930

 

Stock-based compensation

 

 

8,168

 

 

 

5,899

 

Lease liability

 

 

648

 

 

 

1,125

 

Accrued expenses and other, net

 

 

4,208

 

 

 

3,309

 

Total deferred tax assets

 

 

126,401

 

 

 

86,314

 

Deferred tax liabilities:

 

 

 

 

 

 

Right-of use asset

 

 

(313

)

 

 

(531

)

Equity method investment

 

 

(140

)

 

 

(302

)

Net of deferred tax assets and liabilities

 

 

125,948

 

 

 

85,481

 

Less: valuation allowance

 

 

(125,948

)

 

 

(85,481

)

Net deferred tax assets

 

$

 

 

$

 

Schedule of Domestic and Foreign Pre-Tax Loss

Income tax benefit

For the three years in the period ended December 31, 2022, domestic and foreign pre-tax loss were (in thousands):

 

 

 

Year ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Loss before income taxes - Domestic

 

$

(163,175

)

 

$

(107,723

)

 

$

(71,769

)

Income (loss) before income taxes - Foreign

 

 

(743

)

 

 

82

 

 

 

(2,043

)

Loss before income taxes - Consolidated

 

$

(163,918

)

 

$

(107,641

)

 

$

(73,812

)

Schedule of Reconciliation of Income Tax Expense

A reconciliation of income tax expense to the amount computed by applying the statutory federal income tax rate to the loss from operations for the three years in the period ended December 31, 2022 is as follows (in thousands):

 

 

 

Year ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Expected income tax benefit at federal statutory rate

 

$

(34,423

)

 

$

(22,605

)

 

$

(15,417

)

State income tax benefit, net of federal benefit

 

 

(128

)

 

 

(7,083

)

 

 

(4,886

)

Tax effect of

 

 

 

 

 

 

 

 

 

Change in valuation allowance

 

 

39,733

 

 

 

34,495

 

 

 

22,242

 

R&D credit

 

 

(10,918

)

 

 

(7,117

)

 

 

(2,597

)

Stock-based compensation

 

 

781

 

 

 

1,196

 

 

 

539

 

Australian tax incentive

 

 

266

 

 

 

27

 

 

 

215

 

State rate change

 

 

3,243

 

 

 

(8

)

 

 

(5

)

Other

 

 

1,446

 

 

 

1,095

 

 

 

(91

)

Provision for income taxes

 

$

 

 

$

 

 

$

 

Schedule of Unrecognized Tax Benefits

Changes to the Company’s unrecognized tax benefits are summarized in the following table (in thousands):

 

 

 

Year ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Beginning balance

 

$

1,553

 

 

$

1,092

 

 

$

886

 

Increase (decrease) for prior year tax positions

 

 

837

 

 

 

(34

)

 

 

(163

)

Increase (decrease) for current year tax positions

 

 

1,720

 

 

 

495

 

 

 

369

 

Ending balance

 

$

4,110

 

 

$

1,553

 

 

$

1,092